lenacapavir 300 MG Oral Tablet [Sunlenca]

RxNorm concept 2625896, branded drug (sbd). Prescribable name: Sunlenca 300 MG Oral Tablet.

RxCUI: 2625896
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2625896 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

lenacapavir 2625651

Other names

Sunlenca 300 MG Oral Tablet

Related concepts

lenacapavir 300 MG (SCDC, consists of)
lenacapavir 300 MG [Sunlenca] (SBDC, consists of)
{4 (lenacapavir 300 MG Oral Tablet [Sunlenca]) } Pack [Sunlenca 4-Tablet Pack] (BPCK, contained in)
{5 (lenacapavir 300 MG Oral Tablet [Sunlenca]) } Pack [Sunlenca 5-Tablet Pack] (BPCK, contained in)
Oral Tablet (DF, has dose form)
Sunlenca (BN, has ingredient)
lenacapavir 300 MG Oral Tablet (SCD, tradename of)

Linked data

NDCs

61958300103

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2625896 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2625896 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2625896. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.